ProterixBio solutions: overview
Flexible and efficient clinical grade biomarker testing – for research or clinical applications
Our clinical laboratory has extensive experience adapting a variety of commercially available immuno / protein assay reagent-systems for clinical grade or fit-for-purpose performance in target populations. We are technology-agnostic, deploying the right tool for the project at hand, and our work to date spans a wide range of therapeutic areas – including infectious disease, respiratory disease, neurodegenerative disease and cardiovascular disease.
Our key customer segments include hospitals / medical centers, pharma / biotech, and companies providing or seeking to develop advanced diagnostic testing solutions. Selected examples of ongoing, executed or planned end-to-end research or clinical solutions include:
- Development, validation and delivery of protein biomarker testing – on established and emerging technology platforms
- Validation of end-to-end assay performance under CLIA
- Implementation of time-sensitive clinical testing
- Evaluation of devices and pre-analytical protocols to determine feasibility of a patient-centric clinical test
- Screening of reagents for identified targets to determine applicable assay performance
- Specificity testing, assay development and optimization in preparation for resting of human specimen collections
- HIPAA-compliant software solution for ordering, accessioning and results reporting
If you are interested in a CLIA testing partner or need an end-to-end immuno / protein assay solution for research or clinical purposes, please contact us to learn more about our custom immunoassay services.
Learn about our assay development, validation and testing services